Cancer

TransCode Therapeutics, Inc. Announces Proposed Public Offering of Common Stock

BOSTON, July 22, 2024 (GLOBE NEWSWIRE) -- TransCode Therapeutics, Inc. (Nasdaq: RNAZ) (“TransCode” or the “Company”), a clinical-stage RNA oncology…

1 year ago

Media Invited to Science Webinar on Projects Launching to Space Station on Northrop Grumman’s Cygnus Spacecraft

KENNEDY SPACE CENTER, Fla., July 22, 2024 /PRNewswire/ -- The International Space Station (ISS) National Laboratory will host a science…

1 year ago

Relentless Health to Partner With Firefighters to Deliver PFAS Testing

Relentless Health (formerly Diagnose Early) is partnering with the Professional Firefighters Association of South Carolina (PFFASC) to deliver at-home PFAS…

1 year ago

Varian Announces Powerful Functionality, Expanding Versatility and Connectivity for its Ethos Adaptive Radiotherapy System

Technology Upgrades Remove Complexity to Enable Wider Access to Highly Personalized Cancer Care PALO ALTO, Calif., July 22, 2024 /PRNewswire/…

1 year ago

MIRA Pharmaceuticals Reveals Preclinical Success: Ketamir-2 Optimized for Brain Delivery, Avoiding Ketamine’s Drug Resistance

New findings highlight potential advantages of MIRA's novel oral ketamine analog for treating neurological and neuropsychiatric disorders MIAMI, FL /…

1 year ago

HOOKIPA Pharma Announces Leadership Changes to Intensify Focus on HB-200

Director Dr. Malte Peters named Chief Executive Officer and Director Terry Coelho named Executive Vice President and Chief Financial OfficerCompany…

1 year ago

Navigating the Radiological Landscape: Insights into Radiotherapy and Nuclear Medicine Markets

Advancements in AI (Artificial Intelligence) technology is poised to revolutionize radiotherapy, enhancing patient outcomes, and streamlining clinical workflows. Meanwhile, the…

1 year ago

Cell BioEngines Secures an Additional $2 Million in Funding From SOSV and the Empire State Development’s New York Ventures

NEW YORK, July 20, 2024 (GLOBE NEWSWIRE) -- Cell BioEngines, Inc., a New York, USA-based company researching stem cells in…

1 year ago

The Alberta Cancer Foundation’s Enbridge Tour Alberta for Cancer Passes $100 Million Milestone in its 16th Year

Over $7.3 million raised this year alone for Albertans facing cancer in Alberta’s largest cycling fundraiserSTRATHMORE, Alberta, July 20, 2024…

1 year ago